IDXX · Idexx Laboratories Inc /De
$544.32
+4.96 (+0.92%)
At close · Jul 24
Market Cap
$42.94B
Shares
78.88M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-15 | 2026-05-12 | |
| 8-K | 2026-05-05 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| DEF 14A | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-26 | 2026-03-24 | |
| 10-K | 2026-02-20 | 2025-12-31 | |
| 8-K | 2026-02-13 | — | |
| 8-K | 2026-02-02 | — | |
| 8-K | 2026-01-13 | 2026-01-11 | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-10-07 | 2025-10-06 | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-05-09 | 2025-05-07 | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-03-28 | 2024-12-31 | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-02-14 | 2025-02-13 | |
| 8-K | 2025-02-03 | — | |
| 8-K | 2024-12-12 | 2024-12-06 | |
| 8-K | 2024-12-09 | 2024-12-03 | |
| 8-K | 2024-11-21 | 2024-11-20 | |
| 8-K | 2024-11-12 | 2024-11-08 | |
| 8-K | 2024-11-06 | 2024-10-31 | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K/A | 2024-10-31 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-05-10 | 2024-05-06 | |
| 8-K | 2024-05-01 | — | |
| 10-Q | 2024-05-01 | 2024-03-31 | |
| DEF 14A | 2024-03-27 | 2023-12-31 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-02-05 | — | |
| 8-K | 2023-12-07 | 2023-12-05 | |
| 8-K | 2023-11-01 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-08-01 | — | |
| 10-Q | 2023-08-01 | 2023-06-30 | |
| 8-K | 2023-07-12 | 2023-07-11 | |
| 8-K | 2023-05-19 | 2023-05-17 | |
| 8-K | 2023-05-02 | — | |
| 10-Q | 2023-05-02 | 2023-03-31 | |
| DEF 14A | 2023-03-31 | 0001-01-01 | |
| 10-K | 2023-02-16 | 2022-12-31 |
Showing 1–50 of 90 filings
Key facts
CIK
874716
CUSIP
45168D104
13F (30d)
337 filings
330 filers
Visit website
Investor relations